Daily Stock Analysis, BPMX, Biopharmx Corp, priceseries

Biopharmx Corp. Daily Stock Analysis
Stock Information
Open
0.11
Close
0.11
High
0.12
Low
0.11
Previous Close
0.11
Daily Price Gain
0.00
YTD High
0.90
YTD High Date
Apr 28, 2017
YTD Low
0.10
YTD Low Date
Dec 9, 2017
YTD Price Change
-0.27
YTD Gain
-70.23%
52 Week High
0.90
52 Week High Date
Apr 28, 2017
52 Week Low
0.10
52 Week Low Date
Dec 9, 2017
52 Week Price Change
-0.28
52 Week Gain
-71.45%
Company Information
Stock Symbol
BPMX
Exchange
NYSE MKT
Company URL
http://www.biopharmx.com
Company Phone
650-889-5020
CEO
Anja B. Krammer
Headquarters
California
Business Address
1505 ADAMS DRIVE, SUITE D, MENLO PARK, CA 94025
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001504167
About

BioPharmX Corp. engages in providing healthcare products through platform technologies for pharmaceutical, over-the-counter and supplement applications in dermatology. The company was founded by James R. Pekarsky on August 30, 2010 and is headquartered in Menlo Park, CA.

Description

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health and dermatology markets. The company offers prescription and over-the-counter (OTC) products in oral, topical, and injectable forms. It provides VI2OLET iodine, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and for the alleviation of symptoms of fibrocystic breast condition (FBC). The company's clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician's practices, including obstetricians and gynecologists, dermatologists, and general practitioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.